157 related articles for article (PubMed ID: 16645232)
1. Simultaneous measurements of KL-6 and SP-D in patients undergoing thoracic radiotherapy.
Matsuno Y; Satoh H; Ishikawa H; Kodama T; Ohtsuka M; Sekizawa K
Med Oncol; 2006; 23(1):75-82. PubMed ID: 16645232
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of KL-6 are useful biomarkers for severe radiation pneumonitis.
Goto K; Kodama T; Sekine I; Kakinuma R; Kubota K; Hojo F; Matsumoto T; Ohmatsu H; Ikeda H; Ando M; Nishiwaki Y
Lung Cancer; 2001 Oct; 34(1):141-8. PubMed ID: 11557124
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of serum pulmonary surfactant proteins a and d for the early detection of radiation pneumonitis.
Sasaki R; Soejima T; Matsumoto A; Maruta T; Yamada K; Ota Y; Kawabe T; Nishimura H; Sakai E; Ejima Y; Sugimura K
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):301-7. PubMed ID: 11380215
[TBL] [Abstract][Full Text] [Related]
4. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy.
Yamashita H; Kobayashi-Shibata S; Terahara A; Okuma K; Haga A; Wakui R; Ohtomo K; Nakagawa K
Radiat Oncol; 2010 May; 5():32. PubMed ID: 20459699
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors.
Hara R; Itami J; Komiyama T; Katoh D; Kondo T
Chest; 2004 Jan; 125(1):340-4. PubMed ID: 14718465
[TBL] [Abstract][Full Text] [Related]
6. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.
Daimon T; Tajima S; Oshikawa K; Bando M; Ohno S; Sugiyama Y
Intern Med; 2005 Aug; 44(8):811-7. PubMed ID: 16157978
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants of SP-D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy.
Xu L; Jiang J; Li Y; Zhang L; Li Z; Xian J; Jiang C; Diao Y; Su X; Xu H; Zhang Y; Zhang T; Yang Z; Tan B; Li H
Cancer Med; 2019 May; 8(5):2599-2611. PubMed ID: 30897289
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis.
Takahashi H; Imai Y; Fujishima T; Shiratori M; Murakami S; Chiba H; Kon H; Kuroki Y; Abe S
Eur Respir J; 2001 Mar; 17(3):481-7. PubMed ID: 11405529
[TBL] [Abstract][Full Text] [Related]
11. [The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].
Sugimoto H; Okada E; Hashimoto N; Suzuki S; Yoshida H; Totani Y; Ameshima S; Ishizaki T; Miyamori I
Rinsho Byori; 2000 Jun; 48(6):554-60. PubMed ID: 10897675
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
13. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease.
Al-Salmi QA; Walter JN; Colasurdo GN; Sockrider MM; Smith EO; Takahashi H; Fan LL
Chest; 2005 Jan; 127(1):403-7. PubMed ID: 15654008
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of serum KL-6 as a predictive marker of radiation pneumonitis in patients with breast-conservation therapy.
Tokiya R; Hiratsuka J; Yoshida K; Imai S; Kajihara Y; Imajo Y
Int J Clin Oncol; 2004 Dec; 9(6):498-502. PubMed ID: 15616881
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.
Yanaba K; Hasegawa M; Takehara K; Sato S
J Rheumatol; 2004 Jun; 31(6):1112-20. PubMed ID: 15170923
[TBL] [Abstract][Full Text] [Related]
17. Elevation of serum KL-6 glycoprotein or surfactant protein-D in adult T-cell leukemia with distinct pulmonary complications.
Osaka A; Yanagihara K; Yamada Y; Hasegawa H; Inokuchi N; Hayashi T; Komoda M; Nakamura S; Aoyama M; Sawada T; Kamihira S
Tohoku J Exp Med; 2009 Jun; 218(2):99-105. PubMed ID: 19478465
[TBL] [Abstract][Full Text] [Related]
18. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
Nakamura M; Ogura T; Miyazawa N; Tagawa A; Kozawa S; Watanuki Y; Takahashi H
Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940
[TBL] [Abstract][Full Text] [Related]
19. Analysis of KL-6 and SP-D as disease markers in bird fancier's lung.
Janssen R; Grutters JC; Sato H; van Velzen-Blad H; Zanen P; Kohno N; Welsh KI; du Bois RM; van den Bosch JM
Sarcoidosis Vasc Diffuse Lung Dis; 2005 Mar; 22(1):51-7. PubMed ID: 15881280
[TBL] [Abstract][Full Text] [Related]
20. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis.
Arai S; Kurasawa K; Maezawa R; Owada T; Okada H; Fukuda T
Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
